YC Drug Discovery and Delivery Companies
72 Y Combinator drug discovery and delivery startups with verified founder contacts, batch info, and company data.
72
Companies
66
Active
1
Acquired
2
Public
YC Company Directory
50 companies
Company | Batch | Description | Status | Location | Team | Site | Founders | Reveal |
|---|---|---|---|---|---|---|---|---|
AbInitio Bio | X26 | The Intelligence layer for Drug Manufacturing | Active | Boston, MA, USA | 2 | Daniel Mukasa, Nisha Gopal | Reveal | |
CellType | W26 | The agentic drug company. We simulate human biology. | Active | New York City, NY, USA | 2 | David van Dijk, Ivan Vrkic, David van Dijk | Reveal | |
CellType | W26 | The agentic drug company. We simulate human biology. | Active | New York, NY, USA | 2 | David van Dijk, Ivan Vrkic | Reveal | |
Ditto Biosciences | W26 | Evolutionary intelligence for autoimmune disease | Active | San Francisco, CA, USA | 3 | Dennis Sun, Adair Borges, Emily Weiss | Reveal | |
Ditto Biosciences | W26 | Evolutionary therapies for autoimmune disease | Active | San Francisco, CA, USA | 3 | Adair Borges, Dennis Sun, Emily Weiss | Reveal | |
Origin | W26 | AI and Data for Cancer Therapeutics | Active | San Francisco, CA, USA | 4 | Yash Rathod, Malhar Bhide | Reveal | |
Strand AI | W26 | Curated multimodal datasets for biology AI | Active | San Francisco, CA, USA | 2 | Yue Dai, Oded Falik | Reveal | |
Adventris Pharmaceuticals | W23 | Adventris makes cancer vaccines | Active | Baltimore, MD, USA | 7 | Jen Herbach, William Collis, Mark Yarchoan, Jenny Lesser Herbach | Reveal | |
Diffuse Bio | W23 | Generative AI for protein design | Active | San Francisco, CA, USA | 10 | Namrata Anand | Reveal | |
Invitris | W23 | Creating new protein-based drugs at scale | Active | Munich, BY, Germany | 6 | Patrick Grossmann, Kilian Vogele | Reveal | |
Lavo Life Sciences | W23 | AI for drug formulation | Inactive | — | 3 | Scott Swarthout, Zach Glick, Derek Metcalf | Reveal | |
Lavo Life Sciences | W23 | AI for drug formulation | Inactive | — | 3 | Scott Swarthout, Zach Glick, Derek Metcalf | Reveal | |
Miracle | W23 | Accelerate clinical trials with real-time, actionable insights | Active | San Francisco, CA, USA | 7 | Jin Kim | Reveal | |
Miracle | W23 | Accelerate clinical trials with real-time, actionable insights | Active | San Francisco, CA, USA | 6 | Jin Kim | Reveal | |
Novelcare | W23 | Empowering every doctor and every patient to participate in research | Active | New York City, NY, USA; Remote | 5 | Ethan Bond, Jason Marmon | Reveal | |
Persist AI | W23 | Developing long-lasting drug formulations 50% faster | Active | Sacramento, CA, USA | 6 | Karthik Raman, Christopher Shelner | Reveal | |
Persist AI | W23 | Developing long-lasting drug formulations 50% faster | Active | Woodland, CA, USA | 6 | Karthik Raman, Christopher Shelner | Reveal | |
Rosebud Biosciences | W22 | Growing micro-organs to find new drugs | Active | San Francisco, CA, USA | 3 | Kitch Wilson, Evan Lyall | Reveal | |
WhiteLab Genomics | W22 | Unleashing the potential of DNA and RNA based therapies using AI | Active | Paris, Île-de-France, France; Boston, MA, USA | 40 | David Delbourgo, Julien Cottineau | Reveal | |
Abalone Bio | W20 | We create activating antibodies to treat diseases others can’t. | Active | San Francisco, CA, USA | 14 | Richard Yu, Gustavo Pesce | Reveal | |
Abalone Bio | W20 | We create activating antibodies to treat diseases others can’t. | Active | Emeryville, CA, USA | 14 | Richard Yu, Gustavo Pesce | Reveal | |
Algen Biotechnologies | W20 | Using CRISPR to find treatments for cancer and inflammation | Active | San Francisco, CA, USA | 15 | Chun-Hao Huang, Christine Du | Reveal | |
Algen Biotechnologies | W20 | Using CRISPR to find treatments for cancer and inflammation | Active | San Francisco, CA, USA | 13 | Chun-Hao Huang, Christine Du | Reveal | |
Dropprint Genomics | W20 | The better way to run single cell genomics | Acquired | San Francisco, CA, USA | 2 | Rachel Gate, Meena Subramaniam, Jimmie Ye | Reveal | |
Felix Biotechnology | W20 | We’re creating programmable therapies | Inactive | San Francisco, CA, USA | 6 | Robert McBride, Vivek Mutalik, Paul Turner, Natalie Ma | Reveal | |
General Proximity | W20 | The next generation of induced-proximity medicines. | Active | San Francisco, CA, USA | 15 | Armand Cognetta | Reveal | |
General Proximity | W20 | The next generation of induced-proximity medicines. | Active | San Francisco, CA, USA | 15 | Armand Cognetta | Reveal | |
Gamgee | S26 | Scalable Personalised Cancer Treatment | Active | San Francisco, CA, USA; Remote | 2 | Paul Conyngham, Paul Steven Conyngham | Reveal | |
b12 Labs | S25 | Making hard molecules for Pharma and Biotech | Active | San Francisco, CA, USA | 3 | Zlatko Jončev, Andres Bran | Reveal | |
Convexia | S25 | The world's first AI-maximalist pharma company | Active | San Francisco, CA, USA | 4 | Ayaan Parikh, Rahul Vijayan | Reveal | |
Ångström AI | S24 | Gen AI molecular simulations that reproduce wetlab results | Active | San Francisco, CA, USA | 5 | Jose Miguel Hernandez Lobato, Laurence Midgley, Javier Antoran | Reveal | |
Ångström AI | S24 | Gen AI molecular simulations that reproduce wetlab results | Active | San Francisco, CA, USA | 5 | Javier Antoran, Jose Miguel Hernandez Lobato, Laurence Midgley | Reveal | |
Biocartesian | S24 | Converting biology into digital molecular maps | Active | Philadelphia, PA, USA | 2 | Ian Dardani, Jess Li | Reveal | |
Biocartesian | S24 | Converting biology into digital molecular maps | Active | San Francisco, CA, USA | 2 | Ian Dardani, Jess Li | Reveal | |
Nanograb | S23 | Deliver genes to any cell with AI | Active | London, England, United Kingdom | 5 | Debesh Mandal, Christopher Lau, Shanil Panara | Reveal | |
Olio Labs | S23 | Combination therapeutics for the world's toughest diseases | Active | Remote | 5 | David Tingley, Tom Roseberry | Reveal | |
iollo | S22 | Building Quinn, an AI scientist accelerating pharma/biotech R&D | Active | San Francisco, CA, USA | 4 | Daniel Gomari | Reveal | |
Quinn | S22 | The AI that delivers pharma R&D decisions in days, not months | Active | San Francisco, CA, USA | 4 | Daniel Gomari | Reveal | |
Adaptyv | S21 | We're building fully automated labs for protein engineering | Active | Lausanne, Switzerland | 12 | Julian Englert, Daniel Nakhaee-Zadeh Gutierrez | Reveal | |
Adaptyv | S21 | We're building fully automated labs for protein engineering | Active | Lausanne, VD, Switzerland | 25 | Julian Englert, Daniel Nakhaee-Zadeh Gutierrez, Daniel Gutierrez | Reveal | |
CellChorus | S21 | The dynamic single-cell analysis company | Active | Houston, TX, USA | 4 | Dan Meyer, Navin Varadarajan | Reveal | |
Harmonic Discovery | S21 | Multi-targeted therapeutics to treat complex diseases | Active | New York City, NY, USA; New York, NY, USA; Remote | 8 | Rayees Rahman, J Lee, Marcel Patek, Jason Lee | Reveal | |
Matrubials | S21 | Developing milk-inspired therapeutics for infectious diseases | Active | Davis, CA, USA | 4 | Bruce German, Carlito Lebrilla, David Mills | Reveal | |
Mindstate Design Labs | S21 | Programmable biology company for psychoactive effect design | Active | San Francisco, CA, USA | 7 | Dillan DiNardo, Tom Ray | Reveal | |
Parallel Bio | S21 | Using the immune system to cure disease | Active | San Francisco, CA, USA | 20 | Robert DiFazio, Juliana Hilliard | Reveal | |
Pirouette Pharma | S21 | We make injections as easy as pushing a button! | Active | Boston, MA, USA | 9 | Conor Cullinane, Matthew Kane, Elijah Kapas | Reveal | |
Talus Bio | S21 | Discovering drugs that target the DNA regulome | Active | Seattle, WA, USA | 16 | Alex Federation, Lindsay Pino | Reveal | |
Talus Bio | S21 | Discovering drugs that target the DNA regulome | Active | Seattle, WA, USA | 16 | Alex Federation, Lindsay Pino | Reveal | |
Exonic | F25 | Exonic is an AI-native cell and gene therapeutics company. | Active | San Francisco, CA, USA | 3 | Ben Brimacombe | Reveal | |
Reticular | F24 | Interpretable AI for drug discovery | Active | San Francisco, CA, USA | 2 | John Yang | Reveal |
About YC Drug Discovery and Delivery Companies
Y Combinator has funded 72 drug discovery and delivery companies since its founding in 2005. These startups span from early-stage pre-launch to publicly traded companies, making YC one of the most prolific backers of drug discovery and delivery innovation globally.
66 of these companies are currently active. 1 have been acquired. 2 have gone public. VCBacked tracks verified founder contact information, team sizes, and company status for every YC drug discovery and delivery startup.
Related Industries
Get the full drug discovery and delivery dataset
Verified founder emails, CSV export, and advanced filters for all 72 YC drug discovery and delivery companies.
Sign Up FreeNo credit card required